The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
June 14th 2024
An analysis of the REALISTIC trial from EULAR 2024 details the effects of certolizumab pegol in rheumatoid arthritis based on rheumatoid factor levels and prior TNF inhibitor use.
Fatigue May Artificially Increase Disease Activity Scores in Lupus
Fatigue, a highly multifactorial manifestation of lupus, can be related to disease activity or independent of the disease itself. Investigators determined whether fatigue could be a significant confounder of Physician Global Assessment ratings.
Yoga Program Improves Physical Function in Patients with Knee Osteoarthritis
"Online interventions have the potential to reach a wide audience, allowing exercise to be undertaken from the comfort and convenience of home and thereby overcoming some of the barriers to exercise reported in the osteoarthritis population.”
American College of Rheumatology Releases 2022 Rheumatic Disease Report Card
Rebecca Shepherd, MD, MBA, FACR, FACP, discusses the American College of Rheumatology's 2022 Rheumatic Disease Report Card in depth, including what can be done to improve scores and the next steps for her team.
Rheumatology Research Foundation to Award Grant to Clinical Practice Rheumatologist
The Rheumatology Research Foundation has recently announced a grant, called the Community Practice Innovation Award, which focuses on supporting rheumatology practitioners to conduct their crucial, and potentially life-changing, research.
CLEC2B and Ferroptosis: The Link Between Psoriatic Arthritis and High Cancer Risk?
September 19th 2022CLEC2B, a key gene linked to ferroptosis regulators in psoriatic arthritis, is differentially expressed in a variety of cancers and is associated with immune cell infiltration as well as immune checkpoints.
Q&A: ACR’s Updated Guidelines for Prevention, Treatment of Glucocorticoid-Induced Osteoporosis
The guidelines will provide more options for the treatment and prevention of glucocorticoid-induced osteoporosis and will inform rheumatologists about the requirements for anti-resorptive therapy after anabolic agents are discontinued.
Pegloticase Injection Plus Methotrexate Significantly Increases Response Rate in Patients with Gout
Results were based on the phase 4 MIRROR trial, which analyzed differences in treatment response for concomitant therapy compared with placebo in adults with uncontrolled gout.
Patients with Autoimmune Disease at Greater Complications Risk Following Heart Attack
Investigators believe that coronary intervention, intensified medical therapy, and an aggressive risk factor optimization approach should be available to patients with rheumatic disease presenting with myocardial infarction whenever possible.
Q&A: Determinants of Work, Social Participation in Patients With Psoriatic Arthritis
September 13th 2022In this Q&A, Tamara van Hal, MD, discussed the findings of her study that evaluated the extent of work and activity impairment in patients with psoriatic arthritis and examined determinants associated with this impairment.